Nimica, 100 mg 20 pcs.
€1.00
Out of stock
(E-mail when Stock is available)
Nymica is a non-steroidal anti-inflammatory drug (NSAID) of the sulfonanilide class. It has anti-inflammatory, analgesic and antipyretic effects.
Nimisulide belongs to new generation of NSAIDs, the mechanism of action of which is connected with selective inhibition of cyclooxygenase II and influence on several other factors: inhibition of platelet-activating factor, tumor necrosis factor alpha, inhibition of proteinases and histamine.
Pharmacokinetics
In oral administration, it is well absorbed from the gastrointestinal tract. The maximum concentration of the active substance in plasma is reached 1.5-2.5 hours after taking the drug.
The use of the drug concomitantly with food reduces the absorption rate, but does not affect its degree. Binding to plasma proteins is 99%, the volume of distribution is 0.19-0.35 l/kg. Nimesulide is actively metabolized in the liver with the formation of several metabolites, excreted mainly in the urine (70%) and feces (30%).
In patients with renal insufficiency (creatinine clearance 30-80 ml/min) and in children and elderly patients pharmacokinetic profile of nimesulide did not change significantly.
Indications
Active ingredient
Composition
1 tablet contains:
The active ingredients:
nimesulide – 100 mg
Auxiliary substances:
Starch,
Microcrystalline cellulose,
Colloidal silicon dioxide,
gelatinized starch,
citric acid monohydrate,
purified talc,
sodium salt of starch glycolate,
aspartame,
How to take, the dosage
Orally
The maximum dose for children is 5 mg/kg/day in 2-3 doses.
Interaction
Caution should be exercised when using Nimesulide concomitantly with:
Special Instructions
With caution, use simultaneously with diuretics, blood pressure medications, other analgesic anti-inflammatory drugs, anti-diabetic drugs.
Contraindications
Side effects
Nervous system and sensory organs: rarely – headache, dizziness, somnolence.
Cardiovascular system and blood (hematopoiesis, hemostasis): very rare – thrombocytopenia.
Gastrointestinal system disorders: rarely – nausea, heartburn, stomach pain, tarry stools, melena.
Skin disorders: rarely – petechiae, purpura.
Urogenital system disorders: rarely – oliguria.
Allergic reactions: exanthema, erythema, urticaria.
Pregnancy use
Nimica is contraindicated in pregnancy and lactation.
Similarities
Weight | 0.015 kg |
---|---|
Shelf life | 2 years |
Conditions of storage | In a dry, light-protected place at a temperature not exceeding 25 °C |
Manufacturer | Ipka Laboratories Limited, India |
Medication form | dispersible tablets |
Brand | Ipka Laboratories Limited |
Related products
Buy Nimica, 100 mg 20 pcs. with delivery to USA, UK, Europe and over 120 other countries.